74.76
+0.21(+0.28%)
Currency In USD
| Previous Close | 74.55 |
| Open | 73.66 |
| Day High | 77 |
| Day Low | 73.51 |
| 52-Week High | 77 |
| 52-Week Low | 26.2 |
| Volume | 758,290 |
| Average Volume | 753,495 |
| Market Cap | 4.1B |
| PE | -17.07 |
| EPS | -4.38 |
| Moving Average 50 Days | 55.42 |
| Moving Average 200 Days | 42.19 |
| Change | 0.21 |
If you invested $1000 in Apogee Therapeutics, Inc. (APGE) since IPO date, it would be worth $3,521.43 as of December 04, 2025 at a share price of $74.76. Whereas If you bought $1000 worth of Apogee Therapeutics, Inc. (APGE) shares 1 year ago, it would be worth $1,437.14 as of December 04, 2025 at a share price of $74.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody
GlobeNewswire Inc.
Nov 10, 2025 12:00 PM GMT
Interim Phase 1 results for APG333 exceeded trial objectives, demonstrated a half-life of approximately 55 days, and suppressed key biomarkers for 6 months following a single dose, supporting potential 3- and 6- month dosing Results support developme
Apogee Therapeutics to Participate in Upcoming Conferences
GlobeNewswire Inc.
Nov 03, 2025 12:30 PM GMT
SAN FRANCISCO and BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences. Guggenheim 2nd Annual Healthcare Innovation Co
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million
GlobeNewswire Inc.
Oct 10, 2025 8:01 PM GMT
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory